Sanofi gains approval for Apidra insulin, Intanza vax

Sanofi-aventis has won FDA approval for Apidra SoloSTAR, a prefilled disposable pen, for children with type 1 diabetes and adults with type 1 or 2 diabetes. Apidra, which has been on the market in the US since 2006, is a rapid-acting insulin treatment recommended for use during meals. Last year, the FDA approved Sanofi's long-acting version, Lantus SoloStar, which is indicated or once-daily use. Apidra SoloSTAR also won approval in Canada earlier this month.

- check out the Sanofi release

ALSO:  Sanofi Pasteur got the EMEA green light to market the seasonal flu vaccine Intanza for adults. This is the first vaccine that can be injected into the dermal layer of the skin. The vaccine has a needle 10 times smaller than standard needles, which require injection into the muscle. Release